Azabicyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino [2,3-F]quinoline as 5-HT1A antagonists
    1.
    发明申请
    Azabicyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino [2,3-F]quinoline as 5-HT1A antagonists 审中-公开
    2,3-二氢-1,4-二氧杂环己烯并[2,3-F]喹啉的二甲苯基甲基衍生物作为5-HT 1A拮抗剂

    公开(公告)号:US20060264437A1

    公开(公告)日:2006-11-23

    申请号:US11013577

    申请日:2004-12-16

    CPC分类号: C07D519/00

    摘要: Compounds of the formula are useful for treating the cognitive deficits due to aging, stroke, head trauma, Alzheimer's disease or other neurodegenerative diseases, or schizophrenia, and are also useful for the treatment of disorders such as anxiety, aggression and stress, and for the control of various physiological phenomena, such eating disorders, disorders of thermoregulation, and sleep and sexual dysfunction.

    摘要翻译: 该化合物可用于治疗由于老化,中风,头部创伤,阿尔茨海默病或其他神经变性疾病或精神分裂症引起的认知缺陷,并且还可用于治疗诸如焦虑,侵袭和应激的病症,并且对于 控制各种生理现象,饮食失调,体温调节障碍,以及睡眠和性功能障碍。

    Azabicyclylmethyl derivatives of 7,8-dihydro-1,6,9,-trioxa-3-aza-cyclopenta[a]naphthalene as 5-ht1a antagonists
    2.
    发明申请
    Azabicyclylmethyl derivatives of 7,8-dihydro-1,6,9,-trioxa-3-aza-cyclopenta[a]naphthalene as 5-ht1a antagonists 失效
    7,8-二氢-1,6,9-三氧杂-3-氮杂 - 环戊二烯并[a]萘作为5-ht1a拮抗剂的偶氮二甲基甲基衍生物

    公开(公告)号:US20050085475A1

    公开(公告)日:2005-04-21

    申请号:US10878715

    申请日:2004-06-28

    CPC分类号: C07D519/00

    摘要: Compounds of the formula are useful for treating the cognitive deficits due to aging, stroke, head trauma, Alzheimer's disease or other neurodegenerative diseases, or schizophrenia and are also useful for the treatment of disorders such as anxiety, aggression and stress, and for the control of various physiological phenomena, such eating disorders, disorders of thermoregulation, and sleep and sexual dysfunction.

    摘要翻译: 式的化合物可用于治疗由于老化,中风,头部创伤,阿尔茨海默病或其他神经变性疾病或精神分裂症引起的认知缺陷,并且还可用于治疗诸如焦虑,侵袭和应激等疾病以及用于控制 的各种生理现象,这种进食障碍,体温调节障碍,以及睡眠和性功能障碍。